Back to Search Start Over

WITHDRAWN: Tumor SOCS3 protein expression, instead of SOCS3 promoter methylation status, predicts chemotherapy response and prognosis in advanced NSCLC patients

Authors :
Yu Yao
Tao Zhou
Jin-hong Wang
Dong Kang
De-guang Yang
An-na Shen
Source :
Oncotarget.
Publication Year :
2017
Publisher :
Impact Journals, LLC, 2017.

Subjects

Subjects :
Chemotherapy
business.industry
medicine.medical_treatment
chemistry.chemical_element
Promoter
Methylation
Oncology
chemistry
Cancer research
Medicine
SOCS3
business
Platinum
Chemotherapy response

Details

ISSN :
19492553
Database :
OpenAIRE
Journal :
Oncotarget
Accession number :
edsair.doi...........24eeed96890b0a68cae0bbd05f4f0267
Full Text :
https://doi.org/10.18632/oncotarget.23108
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details